Sapienza's:
Personal's:
Work's:
Pharmaceutical Biotechnology (Biotecnologie Farmaceutiche), defended in Oct. 24, 2019
Master Degree
Protein Targeting Chimeras strategy in favour of the degradation of CK2. A structural point of view.